Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants
Starting soon · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Preterm Birth, Inadequate Milk Production
In brief
This study aims to evaluate the feasibility and effects of nicotinamide riboside (NR) supplementation in lactating mothers of infants expected to be hospitalized in the neonatal intensive care unit (NICU) for at least four weeks.
Key facts
- Study ID
- NCT04614714
- Run by
- University of California, Davis
- People needed
- 40
- Starts
- 2026-06-01
- Expected to finish
- 2026-06-30
- Last updated by the study team
- 2026-05-18
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
Where it is running
- University of California, Davis — Sacramento, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.